Annual Shareholders Equity:
$228.84M+$33.41M(+17.10%)Summary
- As of today, COLL annual stockholders equity is $228.84 million, with the most recent change of +$33.41 million (+17.10%) on December 31, 2024.
- During the last 3 years, COLL annual shareholders equity has risen by +$25.91 million (+12.77%).
- COLL annual shareholders equity is now at all-time high.
Performance
COLL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Shareholders Equity:
$274.81M+$42.60M(+18.35%)Summary
- As of today, COLL quarterly stockholders equity is $274.81 million, with the most recent change of +$42.60 million (+18.35%) on September 30, 2025.
- Over the past year, COLL quarterly shareholders equity has increased by +$40.53 million (+17.30%).
- COLL quarterly shareholders equity is now at all-time high.
Performance
COLL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
COLL Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +17.1% | +17.3% |
| 3Y3 Years | +12.8% | +39.4% |
| 5Y5 Years | +161.7% | +59.1% |
COLL Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +17.4% | at high | +53.6% |
| 5Y | 5-Year | at high | +161.7% | at high | +61.6% |
| All-Time | All-Time | at high | +356.1% | at high | +2345.0% |
COLL Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $274.81M(+18.3%) |
| Jun 2025 | - | $232.21M(-1.0%) |
| Mar 2025 | - | $234.43M(+2.4%) |
| Dec 2024 | $228.84M(+17.1%) | $228.84M(-2.3%) |
| Sep 2024 | - | $234.28M(+8.2%) |
| Jun 2024 | - | $216.58M(-2.5%) |
| Mar 2024 | - | $222.17M(+13.7%) |
| Dec 2023 | $195.43M(+0.3%) | $195.43M(+9.3%) |
| Sep 2023 | - | $178.87M(-10.9%) |
| Jun 2023 | - | $200.81M(+11.7%) |
| Mar 2023 | - | $179.73M(-7.8%) |
| Dec 2022 | $194.84M(-4.0%) | $194.84M(-1.2%) |
| Sep 2022 | - | $197.19M(-0.2%) |
| Jun 2022 | - | $197.61M(+0.8%) |
| Mar 2022 | - | $196.08M(-3.4%) |
| Dec 2021 | $202.93M(+9.1%) | $202.93M(-19.2%) |
| Sep 2021 | - | $251.09M(-0.8%) |
| Jun 2021 | - | $253.07M(+48.8%) |
| Mar 2021 | - | $170.03M(-8.6%) |
| Dec 2020 | $186.03M | $186.03M(+7.7%) |
| Sep 2020 | - | $172.69M(+10.9%) |
| Jun 2020 | - | $155.77M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $141.06M(+61.3%) |
| Dec 2019 | $87.43M(-4.5%) | $87.43M(+3.8%) |
| Sep 2019 | - | $84.26M(-1.8%) |
| Jun 2019 | - | $85.82M(-0.6%) |
| Mar 2019 | - | $86.35M(-5.7%) |
| Dec 2018 | $91.58M(-12.0%) | $91.58M(+29.4%) |
| Sep 2018 | - | $70.78M(-14.4%) |
| Jun 2018 | - | $82.68M(-9.0%) |
| Mar 2018 | - | $90.82M(-12.7%) |
| Dec 2017 | $104.08M(-22.9%) | $104.08M(+8.1%) |
| Sep 2017 | - | $96.27M(+0.8%) |
| Jun 2017 | - | $95.51M(-16.5%) |
| Mar 2017 | - | $114.37M(-15.2%) |
| Dec 2016 | $134.91M(+58.6%) | $134.91M(+81.5%) |
| Sep 2016 | - | $74.33M(-24.7%) |
| Jun 2016 | - | $98.66M(-19.0%) |
| Mar 2016 | - | $121.74M(+43.1%) |
| Dec 2015 | $85.07M(+195.2%) | $85.07M(-9.1%) |
| Sep 2015 | - | $93.56M(-8.6%) |
| Jun 2015 | - | $102.42M(+197.3%) |
| Mar 2015 | - | $34.45M(+381.4%) |
| Dec 2014 | -$89.35M(-31.0%) | -$12.24M |
| Dec 2013 | -$68.22M | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual stockholders equity?
- What is the all-time high annual shareholders equity for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual shareholders equity year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly stockholders equity?
- What is the all-time high quarterly shareholders equity for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly shareholders equity year-on-year change?
What is Collegium Pharmaceutical, Inc. annual stockholders equity?
The current annual shareholders equity of COLL is $228.84M
What is the all-time high annual shareholders equity for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual stockholders equity is $228.84M
What is Collegium Pharmaceutical, Inc. annual shareholders equity year-on-year change?
Over the past year, COLL annual stockholders equity has changed by +$33.41M (+17.10%)
What is Collegium Pharmaceutical, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of COLL is $274.81M
What is the all-time high quarterly shareholders equity for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly stockholders equity is $274.81M
What is Collegium Pharmaceutical, Inc. quarterly shareholders equity year-on-year change?
Over the past year, COLL quarterly stockholders equity has changed by +$40.53M (+17.30%)